IL233059D0 - Synthetic voacangine - Google Patents

Synthetic voacangine

Info

Publication number
IL233059D0
IL233059D0 IL233059A IL23305914A IL233059D0 IL 233059 D0 IL233059 D0 IL 233059D0 IL 233059 A IL233059 A IL 233059A IL 23305914 A IL23305914 A IL 23305914A IL 233059 D0 IL233059 D0 IL 233059D0
Authority
IL
Israel
Prior art keywords
synthetic voacangine
voacangine
synthetic
Prior art date
Application number
IL233059A
Other languages
Hebrew (he)
Original Assignee
Demerx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261590741P priority Critical
Priority to US201261591200P priority
Priority to PCT/US2013/022874 priority patent/WO2013112673A1/en
Application filed by Demerx Inc filed Critical Demerx Inc
Publication of IL233059D0 publication Critical patent/IL233059D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
IL233059A 2012-01-25 2014-06-10 Synthetic voacangine IL233059D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US201261590741P true 2012-01-25 2012-01-25
US201261591200P true 2012-01-26 2012-01-26
PCT/US2013/022874 WO2013112673A1 (en) 2012-01-25 2013-01-24 Synthetic voacangine

Publications (1)

Publication Number Publication Date
IL233059D0 true IL233059D0 (en) 2014-07-31

Family

ID=48873892

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233059A IL233059D0 (en) 2012-01-25 2014-06-10 Synthetic voacangine

Country Status (6)

Country Link
US (3) US8877921B2 (en)
EP (1) EP2807168A4 (en)
AU (1) AU2013212139A1 (en)
CA (1) CA2858820A1 (en)
IL (1) IL233059D0 (en)
WO (1) WO2013112673A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2858105A1 (en) * 2012-01-25 2013-08-01 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
WO2014143201A1 (en) 2013-03-15 2014-09-18 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
WO2016086194A1 (en) 2014-11-26 2016-06-02 Demerx, Inc. Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids
US10448971B2 (en) 2016-12-21 2019-10-22 Medtronic, Inc. Apparatus for forming a passageway in tissue and associated interventional medical systems
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CN110437255B (en) * 2019-09-02 2020-08-21 中国科学院昆明植物研究所 Indole alkaloid or pharmaceutically acceptable salt thereof, preparation method and application thereof, indole alkaloid pharmaceutical composition and application thereof
CN110483515B (en) * 2019-09-02 2020-08-07 中国科学院昆明植物研究所 Ebogaalkaloid or pharmaceutically acceptable salt thereof, preparation method and application thereof, and Ebogaalkaloid pharmaceutical composition and application thereof

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813873A (en) 1957-11-19 Derivatives of the ibogaine alkaloids
US2877229A (en) 1959-03-10 Process for the manufacture of indoles
GB841697A (en) 1956-03-22 1960-07-20 Ciba Ltd Analgesic compositions
GB924042A (en) 1959-03-05 1963-04-18 Geigy Ag J R Process for the decarboxylation of alkyl esters of unsaturated, nitrogen-containing carboxylic acids
US3639408A (en) 1967-06-03 1972-02-01 Shionogi & Co Process for the preparation of isoquinuclidine derivatives
US3516989A (en) 1967-10-02 1970-06-23 American Home Prod Intermediates for total synthesis of iboga alkaloids and means of preparation
FR7131M (en) 1968-01-31 1969-07-21
US3557126A (en) 1969-08-14 1971-01-19 American Home Prod Derivatives of iboga alkaloids
US3574220A (en) 1969-08-14 1971-04-06 American Home Prod 1,7-methano-1h-1-benzazepin-5(4h)-ones
CA982478A (en) 1971-04-12 1976-01-27 Jerome Berk Orally administered drug composition for therapy in the treatment of narcotic drug addiction
US3875011A (en) 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US4375414A (en) 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US3715361A (en) 1971-10-08 1973-02-06 American Cyanamid Co Acyl derivatives of 10-methoxyibogamine
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
FR2296418B1 (en) 1974-12-30 1978-07-21 Anvar
US4272541A (en) 1978-06-02 1981-06-09 Miles Laboratories, Inc. 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them
AU7821581A (en) 1980-12-17 1982-06-24 Sterling Drug Inc. Substitution of aromatic organic compounds
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
CA1188989A (en) 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
US4604365A (en) 1981-06-02 1986-08-05 Electro-Nucleonics, Inc. Immunoprecipitation assay
US4462941A (en) 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
US4499096A (en) 1983-11-18 1985-02-12 Lotsof Howard S Rapid method for interrupting the narcotic addiction syndrome
US5266574A (en) 1984-04-09 1993-11-30 Ian S. Zagon Growth regulation and related applications of opioid antagonists
US4626539A (en) 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4573995A (en) 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
GB8430346D0 (en) 1984-11-30 1985-01-09 Reckitt & Colmann Prod Ltd Analgesic compositions
AT95430T (en) 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Active plaster.
US4806341A (en) 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US4587243A (en) 1985-07-15 1986-05-06 Lotsof Howard S Rapid method for interrupting the cocaine and amphetamine abuse syndrome
US5316759A (en) 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US4857523A (en) 1988-07-18 1989-08-15 Nda International, Inc. Rapid method for attenuating the alcohol dependency syndrome
US5629307A (en) 1989-10-20 1997-05-13 Olney; John W. Use of ibogaine in reducing excitotoxic brain damage
US5075341A (en) 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse
DE4010079C2 (en) 1990-03-29 1992-07-30 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
US5026697A (en) 1990-05-30 1991-06-25 Nda International, Inc. Rapid method for interrupting or attenuating the nicotine/tobacco dependency syndrome
US5152994A (en) 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5283247A (en) 1991-02-06 1994-02-01 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
US5149538A (en) 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5290784A (en) 1991-07-18 1994-03-01 Yueqian Qu Aconitane derivatives used as a medication to treat addiction
ES2123642T3 (en) 1992-04-10 1999-01-16 Merrell Pharma Inc Method for the treatment of cancer by joint therapy with 2'-halometilideno derivatives and a specific antineoplastic agent of phase s or phase m.
EP0652765A4 (en) 1992-06-12 1997-04-09 Des Tyr Dynorphin Partnership Des-tyr dynorphin analogues.
US5256669A (en) 1992-08-07 1993-10-26 Aminotek Sciences, Inc. Methods and compositions for treating acute or chronic pain and drug addiction
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5580876A (en) 1992-09-21 1996-12-03 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
WO1994006426A1 (en) 1992-09-21 1994-03-31 Qin Bo Yi Methods for identifying and using low/non-addictive opioid analgesics
CN1042895C (en) 1992-09-23 1999-04-14 曲曰谦 Medicines composition and its method for treating drop syndrome and de-addiction of drugaddict
WO1994014490A1 (en) 1992-12-23 1994-07-07 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US5865444A (en) 1994-03-21 1999-02-02 Deere & Company Body leveling suspension including a pivoting arrangement
JP2819236B2 (en) 1994-05-06 1998-10-30 日東電工株式会社 Transdermal formulation
US5552406A (en) 1994-06-17 1996-09-03 The Mclean Hospital Corporation Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists
ES2264562T3 (en) 1994-07-25 2007-01-01 Nda International, Inc. USE OF NORIBOGAIN DERIVATIVES TO TREAT CHEMICAL DEPENDENCE IN MAMMALS.
US5591738A (en) 1994-10-14 1997-01-07 Nda International, Inc. Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof
WO1997005869A1 (en) 1995-08-08 1997-02-20 Albany Medical College Ibogamine congeners
US5616575A (en) 1995-12-04 1997-04-01 Regents Of The University Of Minnesota Bioactive tricyclic ibogaine analogs
US5760044A (en) 1996-05-16 1998-06-02 Archer; Sydney Method for treating cocaine and amphetamine dependency
EP0912577A2 (en) 1996-05-21 1999-05-06 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Novel methods of o-demethylation and n-deprotection
EP2246058A1 (en) 1997-09-04 2010-11-03 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
YU98003A (en) 2001-06-11 2006-03-03 Biovitrum Ab. Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
US20030153552A1 (en) 2002-02-14 2003-08-14 Mash Deborah C. Method of treating chemical dependency in mammals and a composition therefor
US6864271B2 (en) 2002-11-12 2005-03-08 The Foundation For The Lsu Health Sciences Center Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives
US6806291B1 (en) 2003-10-09 2004-10-19 The Foundation For The Lsu Health Sciences Center Analgesic compounds, their synthesis and pharmaceutical compositions containing them
US8017151B2 (en) 2004-09-07 2011-09-13 Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center Amphiphilic polymer-protein conjugates and methods of use thereof
WO2007012464A1 (en) 2005-07-26 2007-02-01 Merckle Gmbh Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
AT490237T (en) 2005-08-26 2010-12-15 Medical Res Council Anionically substituted 7-nitroindol derivatives and their use
CN101316840B (en) 2005-11-30 2012-08-08 霍夫曼-拉罗奇有限公司 1,5-substituted indol-2-yl amide derivatives
US7960544B2 (en) 2005-12-16 2011-06-14 Ironwood Pharmaceuticals, Inc. Useful indole compounds
US9625475B2 (en) 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
MX2013000733A (en) 2010-07-23 2013-05-30 Demerx Inc Noribogaine compositions.
EP2481740B1 (en) * 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US8742096B2 (en) 2011-03-28 2014-06-03 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
SG2014011811A (en) 2011-09-15 2014-05-29 Demerx Inc Noribogaine salt ansolvates
JP6134094B2 (en) 2011-11-04 2017-05-24 株式会社神戸製鋼所 Nitrogen oxide removal method
EP2788355A4 (en) 2011-12-08 2015-10-21 Demerx Inc Stereoselective total synthesis of noribogaine
EP2788003A4 (en) 2011-12-09 2015-05-27 Demerx Inc Phosphate esters of noribogaine
EP2830601A4 (en) 2012-03-27 2015-09-23 Albany Medical College Blocking of cue-induced drug reinstatement
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine

Also Published As

Publication number Publication date
US20160311823A1 (en) 2016-10-27
CA2858820A1 (en) 2013-08-01
US8877921B2 (en) 2014-11-04
WO2013112673A1 (en) 2013-08-01
AU2013212139A1 (en) 2014-06-26
US20150094466A1 (en) 2015-04-02
US20130211073A1 (en) 2013-08-15
EP2807168A1 (en) 2014-12-03
EP2807168A4 (en) 2015-10-14
US9469649B2 (en) 2016-10-18

Similar Documents

Publication Publication Date Title
HK1245780B (en) Imidazopyrrolidinone compounds
HRP20181889T1 (en) Tetrahydropyrazolopyrimidine compounds
IL254716D0 (en) Zinc-lysine complex
IL253775D0 (en) נוגדנים בעלי שרשרת קלה מהונדסת היסטידין ובעלי חיים לא אנושיים שעברו שינוי גנטי להכנתם
HK1215183A1 (en) Protein-polymer-drug conjugates --
HK1250690A1 (en) Methods
IL237341D0 (en) Pro-neurogenic compounds
HK1208363A1 (en) New methods
HK1208025A1 (en) Aminoimidazopyridazines
GB201322812D0 (en) No title
EP2836211A4 (en) Novel methods
GB201304182D0 (en) No details
GB201304176D0 (en) No title
HK1200830A1 (en) Substituted pyrrolidine-2-carboxamides -2-
EP2934531A4 (en) Combination
EP2754580A4 (en) Dumptruck
GB201403961D0 (en) No details
GB201214750D0 (en) Compounds
DK3327112T3 (en) Agse-deficient stamme
HK1201200A1 (en) Substituted pyrrolidine-2-carboxamides -2-
GB201209138D0 (en) Compounds
GB201215357D0 (en) Compounds
GB201508422D0 (en) No Title
EP2887803A4 (en) Pro-neurogenic compounds
HK1206726A1 (en) Imidazotriazinone compounds